We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Shears Offer Improved Surgical Performance

By HospiMedica staff writers
Posted on 24 Oct 2007
A new surgical device specifically designed for fine and delicate dissections in open surgeries helps improve patient outcomes.

The Harmonic Focus curved shears, is a new member of the Harmonic advanced energy family of ultrasonic surgical devices. More...
The shears can be used for procedures where precise dissection and efficiency are vital, including thyroidectomies, parotidectomies, and axillary dissections, allowing surgeons to precisely dissect, grasp, coagulate, and cut without exchanging instruments. The small (nine centimeter), light hand piece also seals five-millimeter vessels, as well as lymphatics, and offers advantages in terms of efficiency, performance, and safer dissection near vital structures, when compared to electro-surgery. The Harmonic Focus curved shears is a product of Ethicon Endo-Surgery (EES, Cincinnati, OH, USA), a Johnson & Johnson company (New Brunswick, NJ, USA).

"A significant benefit of the Harmonic Focus curved shears is the minimal thermal spread, which is important to help reduce the risk of nerve injury for patients,” said Peter Angelos, M.D., Ph.D, of the University of Chicago (IL, USA).

Harmonic devices use ultrasonic energy to simultaneously cut and coagulate soft tissue and vessels at much lower temperatures than radiofrequency (RF) based devices, resulting in minimal thermal damage to the surrounding tissue. Since there is no electrical current on the active blade of the device, there is no electrical energy being transferred to or through the patient.


Related Links:
Ethicon Endo-Surgery
Johnson & Johnson

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.